weSRCH - Where Technology Meets Opportunity for in the Business of Science
Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1077 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    Study links diabetes to artificial sweeteners - Jackson Clarion Ledger
      The new research, from the Weizmann Institute of Science in Israel, finds that differences in gut microbes may explain why some people can handle artificial sweeteners just fine while in an unknown percentage of others the sweetener ....more | Save |  Share  Email 22nd Sep 2014 
    Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Zacks.com
      Bidness ETC We note that late last week, Novo Nordisk had received marketing authorization for Xultophy for the treatment of type II diabetes in adults in the EU. EU approval came shortly after approval in Switzerland. The company inte ....more | Save |  Share  Email 22nd Sep 2014 
    Diabetes Drug May Affect Thyroid in Some Patients - WebMD
      Daily Mail Among patients treated for an underactive thyroid, metformin was linked with a 55 percent higher risk for low TSH levels, compared to those who were taking sulfonylurea for their diabetes. "The results of this longitudinal study c ....more | Save |  Share  Email 22nd Sep 2014 
    Storage symptoms more severe in men with comorbid diabetes - News-Medical.net
      A study of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) suggests that the presence of comorbid diabetes is associated with more severe urological symptoms. Specifically, men with Type 2 ....more | Save |  Share  Email 22nd Sep 2014 
    teva pharmaceuticals - Techdirt (blog)
      Specifically, the agency charged several drug makers -- including AbbVie, Abbott Laboratories, which spun off AbbVie, and Teva Pharmaceuticals -- for striking deals that delayed the availability of the widely promoted AndroGel testosterone replacement ...and ....more | Save |  Share  Email 22nd Sep 2014 
    Horizon Pharma to Present at the 21st Annual NewsMakers in the Biotech ... - MarketWatch
      Bidness ETC DUBLIN, IRELAND, Sep 22, 2014 (Marketwired via COMTEX) -- Horizon Pharma plc HZNP, -6.06% a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases ....more | Save |  Share  Email 22nd Sep 2014 
    Esperion Therapeutics to Present at BioCentury's NewsMakers in the Biotech ... - MarketWatch
      ANN ARBOR, Mich., Sep 22, 2014 (BUSINESS WIRE) -- Esperion Therapeutics, Inc. a clinical-stage emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lip ....more | Save |  Share  Email 22nd Sep 2014 
    Aduro BioTech Named One of Fierce 15 Leading Biotech Companies in 2014 - MarketWatch
      BERKELEY, Calif., Sep 22, 2014 (BUSINESS WIRE) -- Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced that it has been named one of the leading biotech companies in 2014 by FierceBiotech, designating ....more | Save |  Share  Email 22nd Sep 2014 
    Baylor College of Medicine recruiting for long-term study of diabetes drug ... - Baylor College of Medicine News (press release)
      With type 2 diabetes on the rise, Baylor College of Medicine is recruiting participants for a groundbreaking study funded by the National Institutes of Health to establish th ....more | Save |  Share  Email 22nd Sep 2014 
    These 3 Biotech Stocks Just Hit New Highs - Benzinga
      The S&P 500 and Dow Jones Industrials are again hitting new highs. And every time a new high is hit, skepticism seems to grow. The question continues to come up, "How much higher can the stock market go?? Two or three years ago, the fear of a m ....more | Save |  Share  Email 22nd Sep 2014 
    Navitor Pharmaceuticals - FierceBiotech
      But when something goes wrong in that process, over- or underactive mTOR action can contribute to metabolic, neurological and inflammatory diseases. Navitor Pharmaceuticals, an early-stage biotech startup, has platform technology that promises to elbow ...Fi ....more | Save |  Share  Email 22nd Sep 2014 
    Mapp named a Fierce 15 biotech - U-T San Diego
      Buoyed by its experimental Ebola drug, Mapp Biopharmaceutical of Sorrento Mesa was included Monday on a prominent list of U.S. biotech companies to watch this year. Cidara Therapeutics, another San Diego biotech firm, also made the list compiled by .. ....more | Save |  Share  Email 22nd Sep 2014 
    Common Diabetes Rx May Affect Thyroid Function - dailyRx
      Daily Mail Metformin, used to treat people with type 2 diabetes, may reduce thyroid-stimulating hormone (TSH) levels in people with diabetes already treated for poor thyroid function, a new study found. "Speak to your endocrinologist about yo ....more | Save |  Share  Email 22nd Sep 2014 
    Biological Products: New FDA Draft Guidance Sheds Light on Reference ... - JD Supra (press release)
      As the Food and Drug Administration (FDA) continues to implement the hotly contested approval pathway for follow-on biologics established by the Biologics Price Competition and Innovation Act (BPCIA) in ....more | Save |  Share  Email 22nd Sep 2014 
    Personalised treatment on horizon for rare genetic disease patients - Pharmaceutical Business Review
      UK researchers have identified the most serious genetic mutations responsible for a rare condition that causes blindness, opening the door for personalised treatment and tailored gene therapies. Bardet- ....more | Save |  Share  Email 22nd Sep 2014 
    Packaging Coordinators completes acquisition of Biotec - Pharmaceutical Business Review
      Biotec is a provider of clinical trials and temperature controlled pharmaceutical services. The company said that the acquisition will help in expanding its presence in the UK/EU region to support global investigati ....more | Save |  Share  Email 22nd Sep 2014 
    Grifols introduces 2000 FVIII IU ALPHANATE assay - Pharmaceutical Business Review
      The company will now supply the largest FVIII and von Willebrand Factor: Ristocetin Cofactor (VWF:RCo) assay available on the market for any plasma-derived FVIII concentrate. Grifols North American Commercial Operations p ....more | Save |  Share  Email 22nd Sep 2014 
    Merck agrees to buy Sigma-Aldrich for $17bn - Pharmaceutical Business Review
      Merck Executive Board chairman Karl-Ludwig Kley said the deal marks a milestone on its transformation journey aimed at turning its three businesses into sustainable growth platforms. "For our life science business it' ....more | Save |  Share  Email 22nd Sep 2014 
    November 22nd Options Now Available For Valeant Pharmaceuticals ... - Forbes
      Investors in Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options begin trading today, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRX options ....more | Save |  Share  Email 22nd Sep 2014 
    Citius Pharmaceuticals, Inc. (Formerly Trail One, Inc.) Completes Merger With ... - MarketWatch
      MAYNARD, MA, Sep 22, 2014 (Marketwired via COMTEX) -- Citius Pharmaceuticals, Inc. (pinksheets:TRLOD) (the "Company" formerly known as Trail One, Inc.) announced today that it completed a Share Exc ....more | Save |  Share  Email 22nd Sep 2014 
    Total record(s) 1077 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>